Literature DB >> 7734071

Abdominal vagotomy attenuates the inhibiting effect of mannitol on the ingestive behavior of rats.

J D Davis1, G P Smith, T M Kung.   

Abstract

Intact and abdominally vagotomized rats were offered for ingestion during a 30-min period a saccharin and glucose solution or another with 0.1 M mannitol added. The addition of mannitol to the test solution caused a large reduction in intake of intact rats caused by a very rapid decline in the rate of licking during the test. This did not occur with the vagotomized rats. This demonstrates that abdominal vagal nerves are necessary for the inhibitory effect of mannitol on the ingestive behavior of rats. Vagotomized rats also differed from the intact ones by ingesting less of the mannitol-free solution. This was suggested to result from accelerated gastric clearance, leading to abnormally rapid stimulation of negative feedback from the small intestine conveyed to the CNS by extravagal pathways.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7734071

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  3 in total

1.  Hyperosmolarity in the small intestine contributes to postprandial ghrelin suppression.

Authors:  Joost Overduin; Tracy S Tylee; R Scott Frayo; David E Cummings
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-05-01       Impact factor: 4.052

2.  Effects of hindbrain melanin-concentrating hormone and neuropeptide Y administration on licking for water, saccharin, and sucrose solutions.

Authors:  John-Paul Baird; Catalina Rios; Jasmine L Loveland; Janine Beck; Alice Tran; Carrie E Mahoney
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-11-07       Impact factor: 3.619

3.  Orexin-A hyperphagia: hindbrain participation in consummatory feeding responses.

Authors:  John-Paul Baird; Angela Choe; Jasmine L Loveland; Janine Beck; Carrie E Mahoney; Julia S Lord; Lindsay A Grigg
Journal:  Endocrinology       Date:  2008-11-13       Impact factor: 4.736

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.